Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability

References

• Chen H, Wan J, Wang Y, Mou D, Liu H, Xu H, Yang X. (2008). A facile nanoaggregation strategy for oral delivery of hydrophobic drugs by utilizing acid-base neutralization reactions. Nanotechnology, 19: 375104.
   Web of Science ®Google Scholar
• Fahr A, Liu X. (2007). Drug delivery strategies for poorly water-soluble drugs. Expert Opin Drug Deliv, 4:403–416.
   PubMed Web of Science ®Google Scholar
• Lipinski C. (2004). Solubility in the design of combinatorial libraries. In: Yan B (ed.) Analysis and Purification Methods in Combinatorial Chemisty. Hoboken, NJ: John Wiley & Sons, Inc.
   Google Scholar
• Gupta P, Chawla G, Bansal AK. (2004). Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility. Mol Pharm, 1:406–413.
   PubMed Web of Science ®Google Scholar
• Matteucci ME, Miller MA, Williams RO, Johnston KP. (2008). Highly supersaturated solutions of amorphous drugs approaching predictions from configurational thermodynamic properties. J Phys Chem B, 112:16675–16681.
   PubMed Web of Science ®Google Scholar
• Parks GS, Snyder LJ, Cattoir FR. (1934). Studies on glass. XI. Some thermodynamic relations of glassy and alpha-crystalline glucose. J Chem Phys, 2:595–598.
   Google Scholar
• Hancock BC, Parks M. (2000). What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res, 17:397–404.
   PubMed Web of Science ®Google Scholar
• Lindfors L, Skantze P, Skantze U, Westergren J, Olsson U. (2007). Amorphous drug nanosuspensions. 3. Particle dissolution and crystal growth. Langmuir, 23:9866–9874.
   PubMed Web of Science ®Google Scholar
• Matteucci ME, Brettmann BK, Rogers TL, Elder EJ, Williams RO, Johnston KP. (2007). Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media. Mol Pharm, 4:782–793.
   PubMed Web of Science ®Google Scholar
• Pan X, Julian T, Augsburger L. (2008). Increasing the dissolution rate of a low-solubility drug through a crystalline-amorphous transition: a case study with indomethacin [correction of indomethicin]. Drug Dev Ind Pharm, 34:221–231.
   PubMed Web of Science ®Google Scholar
• Yamada T, Saito N, Imai T, Otagiri M. (1999). Effect of grinding with hydroxypropyl cellulose on the dissolution and particle size of a poorly water-soluble drug. Chem Pharm Bull, 47:1311–1313.
   PubMed Web of Science ®Google Scholar
• Hasegawa A, Kawamura R, Nakagawa H, Sugimoto I. (1985). Physical properties of solid dispersions of poorly water-soluble drugs with enteric coating agents. Chem Pharm Bull, 33:3429–3435.
   PubMed Web of Science ®Google Scholar
• Okimoto K, Miyake M, Ibuki R, Yasumura M, Ohnishi N, Nakai T. (1997). Int J Pharm, 159:85–93.
   Web of Science ®Google Scholar
• Palanisamy M, Khanam J. (2011). Solid dispersion of prednisolone: solid state characterization and improvement of dissolution profile. Drug Dev Ind Pharm, 37:373–386.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Sunada H. (1997). Comparison of nicotinamide, ethylurea and polyethylene glycol as carriers for nifedipine solid dispersion systems. Chem Pharm Bull, 45:1688–1693.
   PubMed Web of Science ®Google Scholar
• Yamashita K, Nakate T, Okimoto K, Ohike A, Tokunaga Y, Ibuki R et al. (2003). Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int J Pharm, 267:79–91.
   PubMed Web of Science ®Google Scholar
• Aitken-Nichol C, Zhang F, McGinity JW. (1996). Hot melt extrusion of acrylic films. Pharm Res, 13:804–808.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Shah NH, Malick AW, Infeld MH, McGinity JW. (2006). Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers. Drug Dev Ind Pharm, 32:569–583.
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm, 50:47–60.
   PubMed Web of Science ®Google Scholar
• Six K, Berghmans H, Leuner C, Dressman J, Van Werde K, Mullens J et al. (2003). Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion, Part II. Pharm Res, 20:1047–1054.
   PubMed Web of Science ®Google Scholar
• Six K, Verreck G, Peeters J, Brewster M, Van Den Mooter G. (2004). Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers. J Pharm Sci, 93:124–131.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Sunada H. (1998). Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers. Chem Pharm Bull, 46:482–487.
   PubMed Web of Science ®Google Scholar
• Verreck G, Six K, Van den Mooter G, Baert L, Peeters J, Brewster ME. (2003). Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion–Part I. Int J Pharm, 251:165–174.
   PubMed Web of Science ®Google Scholar
• Matteucci ME, Paguio JC, Miller MA, Williams RO, Johnston KP. (2008). Flocculated amorphous nanoparticles for highly supersaturated solutions. Pharm Res, 25:2477–2487.
   PubMed Web of Science ®Google Scholar
• DiNunzio JC, Hughey JR, Brough C, Miller DA, Williams RO, McGinity JW. (2010). Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol Dispersing. Drug Dev Ind Pharm, 36:1064–1078.
   PubMed Web of Science ®Google Scholar
• DiNunzio JC, Miller DA, Yang W, McGinity JW, Williams RO. (2008). Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole. Mol Pharm, 5:968–980.
   PubMed Web of Science ®Google Scholar
• Matteucci ME, Paguio JC, Miller MA, Williams RO, Johnston KP. (2009). Highly supersaturated solutions from dissolution of amorphous itraconazole microparticles at pH 6.8. Mol Pharm, 6:375–385.
   PubMed Web of Science ®Google Scholar
• Miller DA, DiNunzio JC, Yang W, McGinity JW, Williams RO. (2008). Enhanced in vivo absorption of itraconazole via stabilization of supersaturation following acidic-to-neutral pH transition. Drug Dev Ind Pharm, 34:890–902.
   PubMed Web of Science ®Google Scholar
• Hardin TC, Graybill JR, Fetchick R, Woestenborghs R, Rinaldi MG, Kuhn JG. (1988). Pharmacokinetics of itraconazole following oral administration to normal volunteers. Antimicrob Agents Chemother, 32:1310–1313.
   PubMed Web of Science ®Google Scholar
• Shin JH, Choi KY, Kim YC, Lee MG. (2004). Dose-dependent pharmacokinetics of itraconazole after intravenous or oral administration to rats: intestinal first-pass effect. Antimicrob Agents Chemother, 48:1756–1762.
   PubMed Web of Science ®Google Scholar
• Jaruratanasirikul S, Kleepkaew A. (1997). Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole. Eur J Clin Pharmacol, 52:235–237.
   PubMed Web of Science ®Google Scholar
• Lohitnavy M, Lohitnavy O, Thangkeattiyanon O, Srichai W. (2005). Reduced oral itraconazole bioavailability by antacid suspension. J Clin Pharm Ther, 30:201–206.
   PubMed Web of Science ®Google Scholar
• Miller DA, DiNunzio JC, Yang W, McGinity JW, Williams RO. (2008). Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption. Pharm Res, 25:1450–1459.
   PubMed Web of Science ®Google Scholar
• Brewster ME, Vandecruys R, Peeters J, Neeskens P, Verreck G, Loftsson T. (2008). Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions. Eur J Pharm Sci, 34:94–103.
   PubMed Web of Science ®Google Scholar
• Chen X, Matteucci ME, Lo CY, Johnston KP, Williams RO. (2009). Flocculation of polymer stabilized nanocrystal suspensions to produce redispersible powders. Drug Dev Ind Pharm, 35:283–296.
   PubMed Web of Science ®Google Scholar
• Brewster ME, Neeskens P, Peeters J. (2007). Solubilization of itraconazole as a function of cyclodextrin structural space. J Incl Phenom Macrocycl Chem, 57:561–566.
   Web of Science ®Google Scholar
• Mithani SD, Bakatselou V, Tenhoor CN, Dressman JB. (1996). Estimation of the increase in solubility of drugs as a function of bile salt concentration. Pharm Res, 13:163–167.
   PubMed Web of Science ®Google Scholar
• Wong J, Papadopoulos P, Werling J, Rebbeck C, Doty M, Kipp J, Konkel J, Neuberger D. (2006). Itraconazole suspension for intravenous injection: Determination of the real component of complete refractive index for particle sizing by static light scattering. PDA J Pharm Sci Technol, 60:302–313.
   PubMedGoogle Scholar
• Bakatselou V, Oppenheim RC, Dressman JB. (1991). Solubilization and wetting effects of bile salts on the dissolution of steroids. Pharm Res, 8:1461–1469.
   PubMed Web of Science ®Google Scholar
• Dickson JL, Gupta G, Horozov TS, Binks BP, Johnston KP. (2006). Wetting phenomena at the CO2/water/glass interface. Langmuir, 22:2161–2170.
   PubMed Web of Science ®Google Scholar
• Alban L, Dahl AK, Hansen AK, Hejgaard KC, Jensen AL, Kragh M, Thomsen P, Stennsgaard P. (2001). The welfare impact of increased gavaging doses in rats. Anim Welfare, 10, 303–314.
   Web of Science ®Google Scholar
• Gubbins PO, Gurley BJ, Bowman J. (1998). Rapid and sensitive high performance liquid chromatographic method for the determination of itraconazole and its hydroxy-metabolite in human serum. J Pharm Biomed Anal, 16:1005–1012.
   PubMed Web of Science ®Google Scholar
• Vaughn JM, McConville JT, Burgess D, Peters JI, Johnston KP, Talbert RL et al. (2006). Single dose and multiple dose studies of itraconazole nanoparticles. Eur J Pharm Biopharm, 63:95–102.
   PubMed Web of Science ®Google Scholar
• Hiemenz PC, Rajagopalan R. (1997). Principles of Colloid and Surface Chemistry, New York, Marcel Dekker, Inc.
   Google Scholar
• Shi L, Berkland C. (2006). pH-triggered dispersion of nanoparticle clusters. Adv Mater, 18:2315–2319.
   Web of Science ®Google Scholar
• Overhoff KA, Moreno A, Miller DA, Johnston KP, Williams RO. (2007). Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing. Int J Pharm, 336:122–132.
   PubMed Web of Science ®Google Scholar
• Six K, Verreck G, Peeters J, Binnemans K, Berghmans H, Augustijns P, Kinget R, Van Den Mooter G. (2001). Investigation of thermal properties of glassy itraconazole: identification of a monotropic mesophase. Thermochim Acta, 376:175–181.
   Web of Science ®Google Scholar
• Petereit HU, Weisbrod W. (1999). Formulation and process considerations affecting the stability of solid dosage forms formulated with methacrylate copolymers. Eur J Pharm Biopharm, 47:15–25.
   PubMed Web of Science ®Google Scholar
• Miller DA, McConville JT, Yang W, Williams RO 3rd, McGinity JW. (2007). Hot-melt extrusion for enhanced delivery of drug particles. J Pharm Sci, 96:361–376.
   PubMed Web of Science ®Google Scholar
• Liu R, Sadrzadeh N & Constantinides PP. (2000). Micellization and drug solubility enhancement. In: Liu R (ed.) Water-Insoluble Drug Formation. Denver: Interpharm Press.
   Google Scholar
• Hong JY, Kim JK, Song YK, Park JS, Kim CK. (2006). A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. J Control Release, 110:332–338.
   PubMed Web of Science ®Google Scholar
• Zhang X, Tsang AM, Okino MS, Power FW, Knaak JB, Harrison LS et al. (2007). A physiologically based pharmacokinetic/pharmacodynamic model for carbofuran in Sprague-Dawley rats using the exposure-related dose estimating model. Toxicol Sci, 100:345–359.
   PubMed Web of Science ®Google Scholar
• Jain A, Ran Y, Yalkowsky SH. (2004). Effect of pH-sodium lauryl sulfate combination on solubilization of PG-300995 (an anti-HIV agent): a technical note. AAPS PharmSciTech, 5:e45.
   PubMed Web of Science ®Google Scholar
• Naylor LJ, Bakatselou V, Dressman JB. (1993). Comparison of the mechanism of dissolution of hydrocortisone in simple and mixed micelle systems. Pharm Res, 10:865–870.
   PubMed Web of Science ®Google Scholar
• Schamp K, Schreder SA, Dressman J. (2006). Development of an in vitro/in vivo correlation for lipid formulations of EMD 50733, a poorly soluble, lipophilic drug substance. Eur J Pharm Biopharm, 62:227–234.
   PubMed Web of Science ®Google Scholar
• Six K, Daems T, de Hoon J, Van Hecken A, Depre M, Bouche MP et al. (2005). Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion. Eur J Pharm Sci, 24:179–186.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Ogawa M, Hironaka K, Ito K, Sunada H. (2001). A nifedipine coground mixture with sodium deoxycholate. II. Dissolution characteristics and stability. Drug Dev Ind Pharm, 27:951–958.
   PubMed Web of Science ®Google Scholar
• Jinno J, Kamada N, Miyake M, Yamada K, Mukai T, Odomi M et al. (2008). In vitro-in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol. J Control Release, 130:29–37.
   PubMed Web of Science ®Google Scholar
• Crisp MT, Tucker CJ, Rogers TL, Williams RO, Johnston KP. (2007). Turbidimetric measurement and prediction of dissolution rates of poorly soluble drug nanocrystals. J Control Release, 117:351–359.
   PubMed Web of Science ®Google Scholar